Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: BridgeBio Pharma Inc., 3 years.
BridgeBio Pharma Inc.
Director
Coherus Oncology Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Coherus Oncology Inc. June 11, 202571.3%
-
BridgeBio Pharma Inc. June 21, 202474.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | BridgeBio Pharma Inc. | Grant or award | +3,990 | — | — |
| Jun 5, 2026 | Coherus Oncology Inc. | Grant or award | +30,000 | — | — |
| Jun 20, 2025 | BridgeBio Pharma Inc. | Grant or award | +6,589 | — | — |
| Dec 30, 2024 | BridgeBio Pharma Inc. | Option exercise | +79,702 | $10.99 | $875,925 |
| Dec 30, 2024 | BridgeBio Pharma Inc. | Option exercise | +39,851 | $16.68 | $664,715 |
| Dec 30, 2024 | BridgeBio Pharma Inc. | Option exercise | +39,851 | $26.21 | $1,044,495 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.